KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) Short-Term Debt repayments (2017 - 2026)

Johnson & Johnson's Short-Term Debt repayments history spans 18 years, with the latest figure at $3.2 billion for Q1 2026.

  • On a quarterly basis, Short-Term Debt repayments rose 52.03% to $3.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $13.4 billion, a 25.62% increase, with the full-year FY2025 number at $12.3 billion, up 30.3% from a year prior.
  • Short-Term Debt repayments hit $3.2 billion in Q1 2026 for Johnson & Johnson, up from $1.8 billion in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for JNJ hit a ceiling of $8.2 billion in Q3 2023 and a floor of $856.0 million in Q2 2022.
  • Historically, Short-Term Debt repayments has averaged $3.6 billion across 5 years, with a median of $3.0 billion in 2024.
  • Biggest five-year swings in Short-Term Debt repayments: surged 529.44% in 2023 and later plummeted 83.48% in 2024.
  • Tracing JNJ's Short-Term Debt repayments over 5 years: stood at $856.0 million in 2022, then skyrocketed by 55.14% to $1.3 billion in 2023, then fell by 16.49% to $1.1 billion in 2024, then surged by 62.85% to $1.8 billion in 2025, then soared by 78.46% to $3.2 billion in 2026.
  • Business Quant data shows Short-Term Debt repayments for JNJ at $3.2 billion in Q1 2026, $1.8 billion in Q4 2025, and $5.5 billion in Q3 2025.